| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.1B | $20.4B | $18.7B | $18.9B | $4.2B | $4.4B | $4.1B | $4.1B |
| Cost of Revenue | $15.3B | $14.8B | $13.9B | $13.7B | $3.2B | $3.2B | $3.0B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.3B | $3.3B | $2.8B | $2.9B | $0.7B | $0.6B | $0.6B | $0.6B |
| Operating Income | $2.6B | — | — | — | — | — | — | — |
| Net Income | $2.1B | $1.9B | $1.5B | $1.7B | $0.2B | $0.5B | $0.4B | $0.5B |
| EPS (Basic) | $6.36 | $5.59 | $4.40 | $4.90 | $0.67 | $1.29 | $1.21 | $1.20 |
| EPS (Diluted) | $6.32 | $5.56 | $4.38 | $4.87 | $0.67 | $1.28 | $1.20 | $1.19 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.9B | $14.3B | $13.4B | $13.6B | $12.7B | $9.3B | $6.1B | $5.7B |
| Current Assets | $7.5B | $7.4B | $6.9B | $7.5B | $6.7B | $3.4B | $3.4B | $3.2B |
| Cash & Equivalents | $4.7B | $4.9B | $4.6B | $4.9B | $4.8B | $1.4B | $1.4B | $1.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.7B | $4.2B | $3.6B | $4.2B | $4.0B | $2.7B | $2.0B | $1.9B |
| Stockholders' Equity | $5.5B | $4.9B | $4.3B | $4.1B | $3.3B | $3.4B | $3.3B | $3.0B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.4B | $2.5B | $1.7B | $1.7B | $2.2B | $2.2B | $2.1B | $1.7B |
| Investing Cash Flow | $-0.6B | $-0.8B | $-0.7B | $-0.6B | $-0.4B | $-0.6B | $-0.4B | $-0.4B |
| Capital Expenditures | $0.7B | $0.8B | $0.7B | $0.6B | $0.4B | $0.6B | $0.4B | $0.4B |
| Financing Cash Flow | $-1.9B | $-1.4B | $-1.4B | $-1.2B | $1.7B | $-1.7B | $-1.5B | $-1.1B |